another new "glitazone" for type 2 diabetes, Actos (pioglitazone)

You'll soon see another new "glitazone" for type 2 diabetes, Actos (pioglitazone).

This is the third one...after Rezulin (troglitazone) and Avandia (rosiglitazone).

These drugs lower blood glucose by improving insulin sensitivity.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote